AstraZeneca stock falls after FDA panel votes against new cancer drug - CNBC

AstraZeneca stock falls after FDA panel votes against new cancer drug - CNBC
Business

Listen to this article

0%

Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug.  An advisory panel for the U.S. Food and Drug Administration late Thurs… [+2498 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected